GameSpot may receive revenue from affiliate and advertising partnerships for sharing this content and from purchases through links. Even though Subnautica 2 is in early access, there are still ...

The first Minecraft 26.2 pre-release is here for Java Edition, but there's some bad news if you've been taking advantage of the sandbox game's new peer-to-peer multiplayer, which was implemented in a ...

It’s great to have a robot vacuum that can help you sweep your floors. But as useful as they might be, they’re not designed to tackle wet messes like spills or your dog’s muddy paw prints. A robotic ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Evan Dent Evan Dent is a writer focusing on vacuums and floor care. For this ...

PCWorld’s editors selected the best PC hardware and software of 2025/2026, highlighting standout products like the AMD Ryzen 9 9950X3D CPU, Nvidia RTX 5070 Ti graphics card, and Steam Deck handheld ...

If you shop at Costco regularly, you know the chain’s reputation for bulk bargains and iconic low-cost staples. In 2025, the company revealed three sales figures that underscore just how much certain ...

Joel O’Leary is a full-time Personal Finance Writer at Motley Fool Money, covering credit cards, bank accounts, investing, mortgages, and other personal finance topics. Joel has been writing about ...

Keep up to date with the most important stories and the best deals, as picked by the PC Gamer team. Your weekly update on everything you could ever want to know about the games you already love, games ...

The great critic Susan Sontag once said that “cinema has done more to shape our perception of war than war itself.” That’s true. But is the genre in decline? Once upon a time, studios and directors ...

While the Java Edition of Xbox and Mojang Studios' sandbox survival game megahit Minecraft came before the Bedrock Edition available on consoles and the Xbox on PC app, it's actually missing a few ...

Moving platform.

A new drug combo of enzalutamide and hormone therapy has been shown to extend survival for men with recurring prostate cancer, reducing death risk by over 40%. The study followed more than 1,000 ...